$AVDL
AVADEL PHARMACEUTICALS PLC

2020 Q4 Form 10-Q Financial Statement

#000101247720000017 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $0.00 $0.00 $14.23M
YoY Change -100.0% -100.0% -28.23%
Cost Of Revenue $0.00 $0.00 $2.823M
YoY Change -100.0% -100.0% -9.52%
Gross Profit $0.00 $0.00 $11.41M
YoY Change -100.0% -100.0% -31.73%
Gross Profit Margin 80.16%
Selling, General & Admin $8.970M $8.423M $5.316M
YoY Change 17.1% 58.45% -78.59%
% of Gross Profit 46.61%
Research & Development $5.290M $5.569M $7.539M
YoY Change -31.83% -26.13% -33.88%
% of Gross Profit 66.1%
Depreciation & Amortization $390.0K $320.0K $630.0K
YoY Change -51.25% -49.21% -65.38%
% of Gross Profit 5.52%
Operating Expenses $14.26M $13.99M $12.86M
YoY Change -8.77% 8.84% -64.52%
Operating Profit -$14.26M -$13.70M -$4.147M
YoY Change 102.27% 230.29% -70.58%
Interest Expense -$3.310M -$3.260M -$3.130M
YoY Change -29.12% 4.15% 4.33%
% of Operating Profit
Other Income/Expense, Net $3.440M $0.00 -$139.0K
YoY Change 2766.67% -100.0% -132.71%
Pretax Income -$14.13M -$16.74M -$6.630M
YoY Change 20.36% 152.53% -59.73%
Income Tax -$2.850M -$5.040M $2.234M
% Of Pretax Income
Net Earnings -$11.28M -$11.70M -$8.864M
YoY Change 311.68% 32.03% -43.8%
Net Earnings / Revenue -62.3%
Basic Earnings Per Share -$0.20 -$0.24
Diluted Earnings Per Share -$193.2K -$0.20 -$0.24
COMMON SHARES
Basic Shares Outstanding 58.27M shares 58.21M shares 37.44M shares
Diluted Shares Outstanding 58.21M shares 37.44M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $222.9M $233.1M $72.50M
YoY Change 247.2% 221.52% -42.14%
Cash & Equivalents $71.72M $83.11M $12.87M
Short-Term Investments $151.2M $149.9M $59.60M
Other Short-Term Assets $798.0K $91.00K $175.0K
YoY Change 645.79% -48.0% -96.2%
Inventory $0.00 $0.00 $2.260M
Prepaid Expenses $1.018M $1.426M $2.757M
Receivables $0.00 $0.00 $8.725M
Other Receivables $22.30M $22.00M $1.700M
Total Short-Term Assets $263.5M $281.7M $88.60M
YoY Change 219.8% 217.93% -40.08%
LONG-TERM ASSETS
Property, Plant & Equipment $359.0K $373.0K $770.0K
YoY Change -34.01% -51.56% -66.35%
Goodwill $16.84M $16.84M $18.49M
YoY Change -8.95% -8.95% 0.0%
Intangibles $0.00 $0.00 $1.019M
YoY Change -100.0% -100.0% -98.53%
Long-Term Investments $0.00 $0.00 $1.500M
YoY Change -100.0% -100.0% -68.75%
Other Assets $24.94M $22.26M $34.93M
YoY Change -36.5% -36.26% 40.59%
Total Long-Term Assets $48.18M $45.95M $67.29M
YoY Change -30.23% -31.71% -44.45%
TOTAL ASSETS
Total Short-Term Assets $263.5M $281.7M $88.60M
Total Long-Term Assets $48.18M $45.95M $67.29M
Total Assets $311.6M $327.6M $155.9M
YoY Change 105.79% 110.17% -42.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.934M $2.660M $3.538M
YoY Change -51.9% -24.82% -68.96%
Accrued Expenses $6.501M $16.40M $17.02M
YoY Change -67.18% -3.64% -17.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $35.00K
YoY Change -100.0% -67.29%
Total Short-Term Liabilities $15.11M $23.01M $31.76M
YoY Change -58.01% -27.56% -32.45%
LONG-TERM LIABILITIES
Long-Term Debt $128.2M $126.5M $120.1M
YoY Change 5.36% 5.32% 5.03%
Other Long-Term Liabilities $4.212M $4.938M $13.97M
YoY Change -52.53% -64.66% -1.26%
Total Long-Term Liabilities $132.4M $131.5M $134.1M
YoY Change 1.43% -1.97% 4.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.11M $23.01M $31.76M
Total Long-Term Liabilities $132.4M $131.5M $134.1M
Total Liabilities $149.4M $156.4M $182.9M
YoY Change -17.31% -14.45% -10.04%
SHAREHOLDERS EQUITY
Retained Earnings -$384.2M -$372.9M -$388.5M
YoY Change -1.8% -4.01% 32.08%
Common Stock $567.5M $566.0M $434.5M
YoY Change 30.51% 30.27% 0.22%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $0.00 $50.00M
YoY Change -100.0% -100.0% 0.0%
Treasury Stock Shares 0.000 shares 0.000 shares 5.407M shares
Shareholders Equity $162.3M $171.2M -$26.96M
YoY Change
Total Liabilities & Shareholders Equity $311.6M $327.6M $155.9M
YoY Change 105.79% 110.17% -42.05%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$11.28M -$11.70M -$8.864M
YoY Change 311.68% 32.03% -43.8%
Depreciation, Depletion And Amortization $390.0K $320.0K $630.0K
YoY Change -51.25% -49.21% -65.38%
Cash From Operating Activities -$19.12M -$10.19M -$7.420M
YoY Change 131.48% 37.33% -63.36%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$30.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $7.310M -$9.270M $3.210M
YoY Change 41.39% -388.79% -87.7%
Cash From Investing Activities $7.240M -$9.300M $3.210M
YoY Change 40.04% -389.72% -87.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 180.0K -20.00K -50.00K
YoY Change -550.0% -60.0% -88.1%
NET CHANGE
Cash From Operating Activities -19.12M -10.19M -7.420M
Cash From Investing Activities 7.240M -9.300M 3.210M
Cash From Financing Activities 180.0K -20.00K -50.00K
Net Change In Cash -11.70M -19.51M -4.260M
YoY Change 273.8% 357.98% -179.63%
FREE CASH FLOW
Cash From Operating Activities -$19.12M -$10.19M -$7.420M
Capital Expenditures -$70.00K -$30.00K $0.00
Free Cash Flow -$19.05M -$10.16M -$7.420M
YoY Change 130.63% 36.93% -63.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001012477
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
AVADEL PHARMACEUTICALS PLC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity File Number
EntityFileNumber
000-28508
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1341933
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Earlsfort Terrace
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 2
dei Entity Address Country
EntityAddressCountry
IE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D02 T380
dei City Area Code
CityAreaCode
1
dei Local Phone Number
LocalPhoneNumber
485-1200
dei Security12b Title
Security12bTitle
Ordinary Shares, nominal value $0.01 per share**
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58272734 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14229000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22334000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48220000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16765000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2823000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5742000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9711000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5569000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7539000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15156000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25160000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8423000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5316000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23431000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22520000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
205000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
406000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
610000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-69000 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
627000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3327000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2384000 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45760000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
-226000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
1866000 USD
us-gaap Restructuring Charges
RestructuringCharges
-43000 USD
us-gaap Restructuring Charges
RestructuringCharges
4600000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
13697000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
18376000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2259000 USD
us-gaap Costs And Expenses
CostsAndExpenses
64985000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13697000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4147000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
20075000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
213000 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
781000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
-906000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
2548000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3259000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3125000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
9686000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
9293000 USD
CY2020Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2019Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-2840000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-139000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-435000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-496000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16743000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6630000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9048000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-26846000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5040000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2234000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9258000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3641000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-8864000 USD
us-gaap Net Income Loss
NetIncomeLoss
18306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30487000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58213000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37436000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51206000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37382000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58213000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37436000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52849000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37382000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-8864000 USD
us-gaap Net Income Loss
NetIncomeLoss
18306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30487000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
534000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-210000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
539000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-309000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
393000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
1000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
5000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
131000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
46000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
66000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
86000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
349000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
753000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-124000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
888000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
444000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11103000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8988000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19194000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30043000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83109000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9774000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
148467000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
54384000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8281000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
3570000 USD
CY2020Q3 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
3058000 USD
CY2019Q4 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2107000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47054000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4264000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
281688000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
82380000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
373000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2866000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3612000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
16836000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18491000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
813000 USD
CY2020Q3 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
3608000 USD
CY2019Q4 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
6322000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22264000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39274000 USD
CY2020Q3 us-gaap Assets
Assets
327635000 USD
CY2019Q4 us-gaap Assets
Assets
151436000 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5554000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
520000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
645000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2660000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6100000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16398000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19810000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3431000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3875000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23009000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35984000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
126520000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
121686000 USD
CY2020Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
11773000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1968000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2319000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4938000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8873000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
156435000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
180635000 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58243000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58243000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42927000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37520000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
582000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
429000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5407000 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
49998000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
565440000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
434391000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372909000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-391215000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21918000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29199000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
327635000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22806000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
171200000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151436000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29199000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-865000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-821000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1389000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60733000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
88000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
742000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
32067000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1109000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
213000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2020Q3 avdl Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
-50000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
92000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
351000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-94000 USD
CY2020Q2 avdl Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
116974000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
33000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-9582000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
355000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
769000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
182125000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11703000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
600000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
47000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-69000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
171200000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2780000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-13018000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8605000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-124000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-229000 USD
avdl Financing Related Contingent Consideration Remeasurement
FinancingRelatedContingentConsiderationRemeasurement
435000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-17777000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-8864000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
31000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-26963000 USD
us-gaap Net Income Loss
NetIncomeLoss
18306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30487000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1297000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1690000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-478000 USD
avdl Acquisition Related Contingent Consideration Remeasurement
AcquisitionRelatedContingentConsiderationRemeasurement
3327000 USD
avdl Acquisition Related Contingent Consideration Remeasurement
AcquisitionRelatedContingentConsiderationRemeasurement
2384000 USD
avdl Financing Related Contingent Consideration Remeasurement
FinancingRelatedContingentConsiderationRemeasurement
496000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4835000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4424000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4582000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1333000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1705000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
177000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45760000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-1750000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
306000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-667000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8281000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2026000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1352000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2465000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1759000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
154000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1859000 USD
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-2036000 USD
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
749000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4051000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
259000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6625000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2379000 USD
avdl Earn Out Payment In Excess Of Acquisition Date Fair Value
EarnOutPaymentInExcessOfAcquisitionDateFairValue
5323000 USD
avdl Earn Out Payment In Excess Of Acquisition Date Fair Value
EarnOutPaymentInExcessOfAcquisitionDateFairValue
8640000 USD
us-gaap Payments For Royalties
PaymentsForRoyalties
866000 USD
us-gaap Payments For Royalties
PaymentsForRoyalties
1374000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3337000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
1399000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29609000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30072000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
17250000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
30075000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
57242000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
124254000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23814000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76962000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33553000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
60570000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
116924000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2006000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
123000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-109000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
179500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
406000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
47000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
73335000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3542000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9774000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9325000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83109000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12867000 USD
us-gaap Interest Paid Net
InterestPaidNet
6469000 USD
us-gaap Interest Paid Net
InterestPaidNet
6469000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1788000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
140000 USD
avdl Foodand Drug Administration Approval Number Of Products
FoodandDrugAdministrationApprovalNumberOfProducts
4 FDA_drug
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-2840000 USD
CY2020Q3 us-gaap Bankruptcy Claims Amount Paid To Settle Claims
BankruptcyClaimsAmountPaidToSettleClaims
800000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1228000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
147056000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1499000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
88000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148467000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
53238000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1151000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
54384000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
136000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
71000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
8000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
64000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
426000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
339000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
886000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
211000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
10789000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
29000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
914000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3020000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
550000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
3570000 USD
CY2020Q3 us-gaap Goodwill Gross
GoodwillGross
16836000 USD
CY2020Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2020Q3 us-gaap Goodwill
Goodwill
16836000 USD
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
18491000 USD
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18491000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
205000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
406000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
610000 USD
CY2019Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
17327000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
6189000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3327000 USD
avdl Business Combination Financing Related Costs
BusinessCombinationFinancingRelatedCosts
435000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
14900000 USD
CY2020Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
0 USD
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5554000 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
11773000 USD
CY2020Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2020Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
1914000 USD
CY2020Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1845000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-69000 USD
CY2020Q3 avdl Business Combination Financing Related Costs
BusinessCombinationFinancingRelatedCosts
0 USD
CY2020Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
0 USD
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2020Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
1914000 USD
CY2020Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2018Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
28840000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
10014000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
2880000 USD
CY2019Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
21706000 USD
CY2019Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
17327000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
6189000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
3762000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
14900000 USD
CY2020Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3641000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
126520000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
121686000 USD
CY2020Q3 avdl Coronavirus Aid Relief And Economic Security Act Cares Act Changein Tax Rate Deferred Tax Liability Income Tax Benefit
CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit
9124000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
3351000 USD
CY2020Q3 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
18753000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5040000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.301
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2234000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.336
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9258000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.023
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.137
CY2020Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
353000 USD
CY2019Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1051000 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1426000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2116000 USD
CY2020Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1477000 USD
CY2019Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
0 USD
CY2020Q3 avdl Guarantee Current
GuaranteeCurrent
364000 USD
CY2019Q4 avdl Guarantee Current
GuaranteeCurrent
454000 USD
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
18593000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
536000 USD
CY2020Q3 avdl Short Term Note Receivable
ShortTermNoteReceivable
24750000 USD
CY2019Q4 avdl Short Term Note Receivable
ShortTermNoteReceivable
0 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
91000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47054000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4264000 USD
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
15479000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
29427000 USD
CY2020Q3 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
1477000 USD
CY2020Q3 avdl Guarantee Noncurrent
GuaranteeNoncurrent
1117000 USD
CY2019Q4 avdl Guarantee Noncurrent
GuaranteeNoncurrent
1367000 USD
CY2020Q3 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
5201000 USD
CY2019Q4 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
6428000 USD
CY2020Q3 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
467000 USD
CY2019Q4 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
575000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22264000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39274000 USD
CY2020Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1897000 USD
CY2019Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
3944000 USD
CY2020Q3 avdl Accrued Social Charges
AccruedSocialCharges
394000 USD
CY2019Q4 avdl Accrued Social Charges
AccruedSocialCharges
592000 USD
CY2020Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
728000 USD
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2949000 USD
CY2020Q3 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
6588000 USD
CY2019Q4 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
6470000 USD
CY2020Q3 avdl Accrued Transaction Fees Current
AccruedTransactionFeesCurrent
2500000 USD
CY2020Q3 avdl Accrued Contract Research Organization Charges
AccruedContractResearchOrganizationCharges
361000 USD
CY2019Q4 avdl Accrued Contract Research Organization Charges
AccruedContractResearchOrganizationCharges
2098000 USD
CY2020Q3 avdl Accrued Contract Manufacturing Organization Liabilities
AccruedContractManufacturingOrganizationLiabilities
1009000 USD
CY2019Q4 avdl Accrued Contract Manufacturing Organization Liabilities
AccruedContractManufacturingOrganizationLiabilities
735000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2921000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3022000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16398000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19810000 USD
CY2020Q3 avdl Accrued Interest Current
AccruedInterestCurrent
1078000 USD
CY2019Q4 avdl Accrued Interest Current
AccruedInterestCurrent
2695000 USD
CY2020Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
1817000 USD
CY2019Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
0 USD
CY2020Q3 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
365000 USD
CY2019Q4 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
455000 USD
CY2020Q3 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
171000 USD
CY2019Q4 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
725000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3431000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3875000 USD
CY2020Q1 avdl Maximum Aggregate Offering Priceof Securities Under Shelf Registration
MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration
250000 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
659000 USD
CY2019Q4 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
981000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3143000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6465000 USD
CY2020Q3 us-gaap Guaranty Liabilities
GuarantyLiabilities
1121000 USD
CY2019Q4 us-gaap Guaranty Liabilities
GuarantyLiabilities
1372000 USD
CY2020Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
15000 USD
CY2019Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
55000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4938000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8873000 USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 avdl Maximum Aggregate Offering Priceof American Depositary Shares Under Shelf Registration
MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
50000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
428000 USD
CY2020Q1 avdl Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock
MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock
0.0999
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5407000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-8864000 USD
us-gaap Net Income Loss
NetIncomeLoss
18306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30487000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58213000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37436000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51206000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37382000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1643000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58213000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37436000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52849000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37382000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15969 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22334000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48220000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15789 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20512 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19544 shares
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
1000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
5000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
131000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
46000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14229000 USD
avdl Percentage Of Royalty Payable On Net Sales
PercentageOfRoyaltyPayableOnNetSales
0.15
CY2020Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
1486000 USD
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
3800000 USD
CY2020Q3 avdl Guarantee Asset Current Carrying Value
GuaranteeAssetCurrentCarryingValue
1481000 USD
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
3800000 USD

Files In Submission

Name View Source Status
0001012477-20-000017-index-headers.html Edgar Link pending
0001012477-20-000017-index.html Edgar Link pending
0001012477-20-000017.txt Edgar Link pending
0001012477-20-000017-xbrl.zip Edgar Link pending
avdl-20200930.htm Edgar Link pending
avdl-20200930.xsd Edgar Link pending
avdl-20200930_cal.xml Edgar Link unprocessable
avdl-20200930_def.xml Edgar Link unprocessable
avdl-20200930_htm.xml Edgar Link completed
avdl-20200930_lab.xml Edgar Link unprocessable
avdl-20200930_pre.xml Edgar Link unprocessable
exhibit311q32020.htm Edgar Link pending
exhibit312q32020.htm Edgar Link pending
exhibit321q32020.htm Edgar Link pending
exhibit322q32020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending